Literature DB >> 15793672

[Position on choice of agents among TNF inhibitors].

B Manger1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15793672     DOI： 10.1007/s00393-005-0708-6

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  2 in total

Review 1.  [Revised recommendations of the Deutsche Gesellschaft für Rheumatologie on therapy with tumor necrosis factor-inhibiting active substances on inflammatory diseases].

Authors:  B Manger
Journal:  Z Rheumatol       Date:  2002-12       Impact factor: 1.372

Review 2.  Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J W J Bijlsma; M Dougados; P Emery; E C Keystone; L Klareskog; P J Mease
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.